The expression of CD58 is markedly elevated in Burkitt’s Lymphoma (BL) compared to BCP-ALL, and it can be used to aid in the diagnosis when BL is suspected but MYC proto-oncogene (C-MYC) rearrangement is negative and the results of surface Ig assessment are controversial (79). Here, CD58 is linked to Burkitt lymphoma.